Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
NeonMind Advances Strategy for Specialty Clinic Launch Company expects to launch first specialty clinic locations by early 2022 NeonMind-branded...
NeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr. Gustavo...
NeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory Board Company Broadens Scientific...
NeonMind to Present at H.C. Wainwright 23rd Annual Global Investment ConferenceVancouver, B.C. - September 8, 2021: NeonMind Biosciences Inc...
Dr. Sagar Parikh, MD Appointed to NeonMind Specialty Clinics Advisory Board Vancouver, B.C. – July 28, 2021...
NeonMind Announces Launch of Functional Mushroom Coffees as Dietary Supplements in the US Vancouver, B.C., Canada -- June 29, 2021...
NeonMind Announces Vitasave Will Carry NeonMind Functional Mushroom Products Vancouver, B.C. - June 9, 2021 -- InvestorsHub NewsWire -- NeonMind...
NeonMind to Commence Trading on the OTCQB Venture MarketVancouver, B.C. - May 28, 2021 -- InvestorsHub NewsWire -- NeonMind Biosciences Inc. (CSE:...
NeonMind Developing Music Playlist for Psychedelic Therapy Sessions Vancouver, B.C. – April 6, 2021 -- InvestorsHub NewsWire...
NeonMind Engages Pharma Executive Philippe Martin to Advance its Psilocybin Drug Candidates for Obesity Vancouver, B.C. - March 9, 2021: NeonMind...
NeonMind Purchases GMP Grade Synthetic Psilocybin from Psygen Labs for Phase 2 Human Clinical Trial Vancouver, B.C. –...
NeonMind Appoints Robert Tessarolo as President and Chief Executive Officer Vancouver, B.C. -- January 27, 2021 -- InvestorsHub...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관